Patent | Date |
---|
Method for predicting prognosis of patient with cancer or inflammatory disease Grant 11,193,172 - Terashima , et al. December 7, 2 | 2021-12-07 |
Method for reducing side effects of immune checkpoint control agent Grant 11,168,137 - Ito , et al. November 9, 2 | 2021-11-09 |
Analgesic Agent And Sedative Agent App 20210220320 - TERASHIMA; Yuya ;   et al. | 2021-07-22 |
Hmgn Partial Peptide And Cancer Therapy Using The Same App 20200407408 - MATSUSHIMA; Kouji ;   et al. | 2020-12-31 |
Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient Grant 10,746,726 - Matsushima , et al. A | 2020-08-18 |
Agent For Controlling Cells Constituting Cancer Microenvironment Or Inflammatory Microenvironment App 20200253896 - Kind Code | 2020-08-13 |
Method for analyzing nucleic acid derived from single cell Grant 10,738,352 - Hashimoto , et al. A | 2020-08-11 |
Agent for controlling cells constituting cancer microenvironment or inflammatory microenvironment Grant 10,722,480 - Terashima , et al. | 2020-07-28 |
Methods and compositions for modulating immune tolerance Grant 10,300,115 - Biragyn , et al. | 2019-05-28 |
Therapeutic Agent For Solid Cancer App 20190125867 - ITO; Satoru ;   et al. | 2019-05-02 |
Method For Predicting Prognosis Of Patient With Cancer Or Inflammatory Disease App 20180237860 - TERASHIMA; Yuya ;   et al. | 2018-08-23 |
Prophylactic and/or therapeutic agent for radiation damage Grant 9,895,331 - Tanaka , et al. February 20, 2 | 2018-02-20 |
Agent For Controlling Cells Constituting Cancer Microenvironment Or Inflammatory Microenvironment App 20180000755 - TERASHIMA; Yuya ;   et al. | 2018-01-04 |
Method For Assessing Therapeutic Effect Of Anti-cancer Agent Having Anti-cd4 Antibody As Active Ingredient App 20170328887 - MATSUSHIMA; Kouji ;   et al. | 2017-11-16 |
Method For Analyzing Nucleic Acid Derived From Single Cell App 20170166959 - Hashimoto; Shin-ichi ;   et al. | 2017-06-15 |
Therapeutic Agent For Solid Cancer App 20170165364 - ITO; Satoru ;   et al. | 2017-06-15 |
Method For Reducing Side Effects Of Immune Checkpoint Control Agent App 20170145099 - ITO; Satoru ;   et al. | 2017-05-25 |
Methods And Compositions For Modulating Immune Tolerance App 20170119858 - Biragyn; Arya ;   et al. | 2017-05-04 |
Methods and compositions for modulating immune tolerance Grant 9,605,044 - Biragyn , et al. March 28, 2 | 2017-03-28 |
Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect Grant 9,156,912 - Matsushima , et al. October 13, 2 | 2015-10-13 |
Prophylactic And/or Therapeutic Agent For Radiation Damage App 20150190356 - Tanaka; Tohru ;   et al. | 2015-07-09 |
Proteins expressed in NK cells Grant 8,946,386 - Matsushima , et al. February 3, 2 | 2015-02-03 |
Methods and Compositions for Modulating Immune Tolerance App 20140341937 - Biragyn; Arya ;   et al. | 2014-11-20 |
Methods and compositions for modulating immune tolerance Grant 8,795,674 - Biragyn , et al. August 5, 2 | 2014-08-05 |
Immunological Reconstitution Promoter Or Prophylactic Agent For Infections Each Of Which Maintains Graft-versus-tumor Effect App 20120027748 - Matsushima; Kouji ;   et al. | 2012-02-02 |
Methods and Compositions for Modulating Immune Tolerance App 20110081370 - Biragyn; Arya ;   et al. | 2011-04-07 |
Molecule associating with intracellular C-terminal domain of receptor Grant 7,759,066 - Matsushima , et al. July 20, 2 | 2010-07-20 |
Method For Promoting Immunotherapy Using An Agent For Elevating Dendritic Cell Precursor Level In Blood App 20100021442 - MATSUSHIMA; Kouji ;   et al. | 2010-01-28 |
Recombinant virus and use thereof App 20090214587 - Kohara; Michinori ;   et al. | 2009-08-27 |
Methods for Obtaining Gene Tags App 20090117538 - Hashimoto; Shin-ichi ;   et al. | 2009-05-07 |
Molecule Associating With Intracellular C-terminal Domain Of Receptor App 20090081693 - MATSUSHIMA; Kouji ;   et al. | 2009-03-26 |
Method for promoting immunotherapy App 20080124307 - Matsushima; Kouji ;   et al. | 2008-05-29 |
Antagonists of MCP-1 function and methods of use thereof Grant 7,297,696 - Laborde , et al. November 20, 2 | 2007-11-20 |
Proteins Expressed In Ink Cells App 20070202501 - Matsushima; Kouji ;   et al. | 2007-08-30 |
Remedy for sarcoidosis and method of treating the same App 20070111956 - Matsushima; Kouji ;   et al. | 2007-05-17 |
Prevention and treatment for GVHD App 20060233710 - Matsushima; Kouji ;   et al. | 2006-10-19 |
Agent eleveting dendritic cell precursor level in blood App 20060210531 - Matsushima; Kouji ;   et al. | 2006-09-21 |
Antagonists of MCP-1 function and methods of use thereof Grant 6,998,407 - Laborde , et al. February 14, 2 | 2006-02-14 |
Antagonists of MCP-1 function and methods of use thereof Grant 6,992,086 - Laborde , et al. January 31, 2 | 2006-01-31 |
Molecules associating to c-terminal domain in receptor cell App 20060008801 - Matsushima; Kouji ;   et al. | 2006-01-12 |
Antagonist of MCP-1 function, and compositions and methods of use thereof Grant 6,962,926 - Laborde , et al. November 8, 2 | 2005-11-08 |
Antagonists of MCP-1 function and methods of use thereof App 20050054668 - Laborde, Edgardo ;   et al. | 2005-03-10 |
Antagonists of MCP-1 function and methods of use thereof Grant 6,809,113 - Laborde , et al. October 26, 2 | 2004-10-26 |
Antagonist of MCP-1 function, and compositions and methods of use thereof App 20040198719 - Laborde, Edgardo ;   et al. | 2004-10-07 |
Antagonists of MCP-1 function and methods of use thereof App 20040127513 - Laborde, Edgardo ;   et al. | 2004-07-01 |
Antagonists of MCP-1 function and methods of use thereof App 20040077680 - Laborde, Edgardo ;   et al. | 2004-04-22 |
Antagonists of MCP-1 function and methods of use thereof Grant 6,677,365 - Laborde , et al. January 13, 2 | 2004-01-13 |
Antagonists of MCP-1 function and methods of use thereof Grant 6,670,364 - Laborde , et al. December 30, 2 | 2003-12-30 |
Antagonists of MCP-1 function and methods of use thereof App 20030105085 - Laborde, Edgardo ;   et al. | 2003-06-05 |
Antagonists of MCP-1 function and methods of use thereof App 20030096705 - Laborde, Edgardo ;   et al. | 2003-05-22 |
Antagonists of MCP-1 function and methods of use thereof App 20030092728 - Laborde, Edgardo ;   et al. | 2003-05-15 |
Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein App 20030032168 - Hirose, Kunitaka ;   et al. | 2003-02-13 |
Sepsis remedy comprising anti-IL-8 antibody as active ingredient App 20030021783 - Kitajima, Masaki ;   et al. | 2003-01-30 |
Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein App 20030022352 - Hirose, Kunitaka ;   et al. | 2003-01-30 |
Novel neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto App 20020151706 - Matsushima, Kouji ;   et al. | 2002-10-17 |
Therapeutic Agent For Acute Lung Injury Resulting From Indirect Causes Comprising Anti-il-8 Antibody As Active Ingredient App 20020141988 - MATSUSHIMA, KOUJI ;   et al. | 2002-10-03 |
Human Adamts-1 Protein, Gene Coding The Same, Pharmaceutical Composition, And Method For Immunologically Assaying Human Adamts-1 Protein App 20020119167 - HIROSE, KUNITAKA ;   et al. | 2002-08-29 |
Reshaped human antibody to human interleukin-8 App 20020082396 - Matsushima, Kouji ;   et al. | 2002-06-27 |
Nucleic acids encoding a novel neutrophil chemotactic factor Grant 6,376,659 - Matsushima , et al. April 23, 2 | 2002-04-23 |
Sepsis Remedy Comprising Anti-il-8 Antibody As Active Ingredient App 20020006405 - KITAJIMA, MASAKI ;   et al. | 2002-01-17 |
Rheumatoid Arthritis Remedy Containing Anti-il-8 Antibody As Active Ingredient App 20010006637 - AKAHOSHI, TOHRU ;   et al. | 2001-07-05 |
Reshaped human antibody to human interleukin-8 Grant 6,245,894 - Matsushima , et al. June 12, 2 | 2001-06-12 |
Method to treat inflammation with humanized anti-IL-8-antibodies Grant 6,024,956 - Matsushima , et al. February 15, 2 | 2000-02-15 |
Polynucleotides which encode reshaped IL-8-specific antibodies and methods to produce the same Grant 5,994,524 - Matsushima , et al. November 30, 1 | 1999-11-30 |
Peptide suppressing I.kappa.B.alpha. phosphorylation Grant 5,981,486 - Matsushima , et al. November 9, 1 | 1999-11-09 |
Method of treating inflammation with antibodies to neutrophil chemotactic factor Grant 5,925,352 - Matsushima , et al. July 20, 1 | 1999-07-20 |
Supression of nephritis-induced protein excretion by anti-IL-8 Grant 5,707,621 - Matsushima January 13, 1 | 1998-01-13 |
Antibodies specific for neutrophic chemotactic factor Grant 5,698,196 - Matsushima , et al. December 16, 1 | 1997-12-16 |
Neutrophil chemotactic factor Grant 5,652,338 - Matsushima , et al. July 29, 1 | 1997-07-29 |
Therapeutic agent for treating wounds using monocyte chemotactic and activating factor Grant 5,646,117 - Matsushima , et al. July 8, 1 | 1997-07-08 |
Method of preparing an active human neutrophil chemotactic factor polypeptide Grant 5,401,643 - Yamada , et al. * March 28, 1 | 1995-03-28 |
Process for producing a human neutrophil chemotactic factor peptide and a recombinant expression vector for the said polypeptide Grant 5,306,627 - Yamada , et al. April 26, 1 | 1994-04-26 |
Cordless telephone communication system Grant 4,930,149 - Matsushima May 29, 1 | 1990-05-29 |